The MET Receptor Tyrosine Kinase is a potential novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma

Recurrent/metastatic head and neck cancer remains a devastating disease with insufficient treatment options. We investigated the MET receptor tyrosine kinase as a novel target for the treatment of head and neck squamous cell carcinoma (HNSCC). MET/phosphorylated-MET and HGF expression were analyzed...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Seiwert, Tanguy Y., Jagadeeswaran, Ramasamy, Faoro, Leonardo, Janamanchi, Varalakshmi, Nallasura, Vidya, Dinali, Mohamed El, Yala, Soheil, Kanteti, Rajani, Cohen, Ezra E.W., Lingen, Mark W., Martin, Leslie, Krishnaswamy, Soundararajan, Klein-Szanto, Andres, Christensen, James, Vokes, Everett E., Salgia, Ravi
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2871252/
https://ncbi.nlm.nih.gov/pubmed/19318576
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-08-2881
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados